INVITRO SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI ISOLATED IN AUSTRIA TO ERYTHROMYCIN AND CIPROFLOXACIN

被引：14

作者：

HIRSCHL, AM ^{[1
]}

WOLF, D ^{[1
]}

BERGER, J ^{[1
]}

ROTTER, ML ^{[1
]}

机构：

[1] KAISER FRANZ JOSEPH KRANKENHAUS,INST PATHOL,A-1100 VIENNA,AUSTRIA

来源：

ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES | 1990年 / 272卷 / 04期

关键词：

D O I：

10.1016/S0934-8840(11)80045-9

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

More than 200 strains of Campylobacter (C.) jejuni/coli isolated in 1985 and 1987/88 from human fecal specimens were tested for their susceptibility to erythromycin and ciprofloxacin. Their MIC90 as assessed by agar dilution tests was 2.0 and 0.5 mg/l, respectively. Thus, all strains were regarded as susceptible to ciprofloxacin. With 2 out of 55 strains of C. coli the MIC of erythromycin was 8.0 mg/l. Therefore, only 3.6% of the C. coli strains were resistant to erythromycin. All 209 strains of C. jejuni proved to be susceptible to erythromycin. © 1990, Gustav Fischer Verlag, Stuttgart · New York. All rights reserved.

引用

页码：443 / 447

页数：5

共 14 条

[1] ANDREASEN JJ, 1987, ACTA PATH MICRO IM B, V95, P189
[2] SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI TO MACROLIDES AND RELATED-COMPOUNDS
ELHARRIF, Z
MEGRAUD, F
MARCHAND, AM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 695 - 697
[3] COMPARATIVE INVITRO ACTIVITIES OF 12 ANTIMICROBIAL AGENTS AGAINST CAMPYLOBACTER SPECIES
FLIEGELMAN, RM
PETRAK, RM
GOODMAN, LJ
SEGRETI, J
TRENHOLME, GM
KAPLAN, RL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) : 429 - 430
[4] SUSCEPTIBILITY OF CAMPYLOBACTER-FETUS SUBSP JEJUNI TO PAROMOMYCIN
FREYDIERE, AM
BARBE, G
GILLE, Y
VINCENT, P
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) : 322 - 323
[5] GOODMAN LJ, 1984, ANTIMICROB AGENTS CH, V25, P505
[6] NEW, EXTENDED BIOTYPING SCHEME FOR CAMPYLOBACTER-JEJUNI, CAMPYLOBACTER-COLI, AND CAMPYLOBACTER-LARIDIS
LIOR, H
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (04) : 636 - 640
[7] Lurian V, 1986, ANTIBIOTICS LAB MED, P93
[8] SUSCEPTIBILITY OF CLINICAL ISOLATES OF CAMPYLOBACTER-JEJUNI TO 16 ANTI-MICROBIAL AGENTS
MICHEL, J
ROGOL, M
DICKMAN, D
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 796 - 797
[9] INVITRO ACTIVITY OF CIPROFLOXACIN COMPARED TO TRIMETHOPRIM-SULFAMETHOXAZOLE AGAINST CAMPYLOBACTER SPP, SHIGELLA SPP AND ENTEROTOXIGENIC ESCHERICHIA-COLI CAUSING TRAVELERS DIARRHEA IN EGYPT
MIKHAIL, IA
BOURGEOIS, AL
HYAMS, KC
PODGORE, JK
LISSNER, CR
WALZ, S
[J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1987, 19 (04) : 479 - 481
[10] ANTIMICROBIAL RESISTANCE OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI WITH SPECIAL REFERENCE TO PLASMID PROFILES OF JAPANESE CLINICAL ISOLATES
SAGARA, H
MOCHIZUKI, A
OKAMURA, N
NAKAYA, R
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) : 713 - 719

← 1 2 →